AstraZeneca and AI Biologics Join Hands to Develop Cancer Drug
AstraZeneca, the prominent Anglo-Swedish pharmaceutical giant, has embarked on a transformative journey in cancer therapeutics through a groundbreaking collaboration with Absci Corporation, a U.S.-based generative